-
1 Comment
Global Hemp Group Inc is currently in a long term uptrend where the price is trading 26.3% above its 200 day moving average.
From a valuation standpoint, the stock is 76032.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 1000000.0.
Global Hemp Group Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 80.3% to $-200K since the same quarter in the previous year.
Finally, its free cash flow fell by 466.6% to $-370K since the same quarter in the previous year.
Based on the above factors, Global Hemp Group Inc gets an overall score of 2/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | CA37953Y2033 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Beta | 1.78 |
---|---|
Market Cap | 105K |
PE Ratio | None |
Target Price | None |
Dividend Yield | 0.0% |
Global Hemp Group Inc. produces and processes industrial hemp in the United States. It focuses on the development of sustainable and green value-added industrial hemp products utilizing the processing of the hemp plant for multi-merchantable applications. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GHG.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025